Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 14527710)

1.

QTc interval prolongation associated with intravenous methadone.

Kornick CA, Kilborn MJ, Santiago-Palma J, Schulman G, Thaler HT, Keefe DL, Katchman AN, Pezzullo JC, Ebert SN, Woosley RL, Payne R, Manfredi PL.

Pain. 2003 Oct;105(3):499-506.

PMID:
14527710
2.

Methadone-associated Q-T interval prolongation and torsades de pointes.

Stringer J, Welsh C, Tommasello A.

Am J Health Syst Pharm. 2009 May 1;66(9):825-33. doi: 10.2146/ajhp070392. Review. Erratum in: Am J Health Syst Pharm. 2010 Jan 15;67(2):94.

PMID:
19386945
3.

QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.

Tschida SJ, Guay DR, Straka RJ, Hoey LL, Johanning R, Vance-Bryan K.

Pharmacotherapy. 1996 Jul-Aug;16(4):663-74. Review.

PMID:
8840374
4.

[Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone].

Laqueille X, Richa S, Kerbage H, Scart-Gres C, Berleur MP.

Encephale. 2012 Feb;38(1):58-63. doi: 10.1016/j.encep.2011.02.005. Epub 2011 May 25. Review. French.

PMID:
22381725
5.

[Drug induced QT prolongation].

Altmann D, Eggmann U, Ammann P.

Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6. Review. German.

PMID:
18365152
6.
7.

Methadone: to ECG or not to ECG...That is still the question.

Cruciani RA.

J Pain Symptom Manage. 2008 Nov;36(5):545-52. doi: 10.1016/j.jpainsymman.2007.11.003. Epub 2008 Apr 28. Review.

PMID:
18440771
8.

Methadone and the heart: what the clinician needs to know.

George S, Moreira K, Fapohunda M.

Curr Drug Abuse Rev. 2008 Nov;1(3):297-302. Review.

PMID:
19630728
9.

An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation.

Gintant G.

Pharmacol Ther. 2011 Feb;129(2):109-19. doi: 10.1016/j.pharmthera.2010.08.008. Epub 2010 Aug 31. Review.

PMID:
20807552
10.

Molecular predictors of drug-induced prolongation of the QT interval.

Dilaveris PE.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Apr;3(2):105-18. Review.

PMID:
15853698
11.

Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.

Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG.

Am Heart J. 2007 Jun;153(6):891-9. Review.

PMID:
17540188
12.

Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.

Kelly DL, Love RC.

Psychopharmacol Bull. 2001 Autumn;35(4):66-79. Review.

PMID:
12397857
13.

QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.

Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F.

Med Res Rev. 2005 Mar;25(2):133-66. Review.

PMID:
15389727
14.

Acquired QT interval prolongation and HERG: implications for drug discovery and development.

Finlayson K, Witchel HJ, McCulloch J, Sharkey J.

Eur J Pharmacol. 2004 Oct 1;500(1-3):129-42. Review.

PMID:
15464027
15.

Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Haefeli WE, Schoenenberger RA, Weiss P, Ritz R.

Intensive Care Med. 1992;18(8):469-73. Review.

PMID:
1289371
16.

QTc interval screening in methadone treatment.

Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC.

Ann Intern Med. 2009 Mar 17;150(6):387-95. Epub 2009 Jan 19.

PMID:
19153406
17.

QTc interval prolongation by d-propoxyphene: what about other analgesics?

Raffa RB, Burmeister JJ, Yuvasheva E, Pergolizzi JV Jr.

Expert Opin Pharmacother. 2012 Jul;13(10):1397-409. doi: 10.1517/14656566.2012.682150. Epub 2012 May 9. Review.

PMID:
22568597
18.

Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?

Mujtaba S, Romero J, Taub CC.

J Cardiovasc Dis Res. 2013 Dec;4(4):229-35. doi: 10.1016/j.jcdr.2013.10.001. Epub 2013 Nov 16. Review.

19.

Outcomes of screening Parkinson's patients for QTc prolongation.

Cunnington AL, Hood K, White L.

Parkinsonism Relat Disord. 2013 Nov;19(11):1000-3. doi: 10.1016/j.parkreldis.2013.07.001. Epub 2013 Jul 17. Review.

PMID:
23871463
20.

Assessment of QTc prolongation for non-cardiac-related drugs from a drug development perspective.

Bonate PL, Russell T.

J Clin Pharmacol. 1999 Apr;39(4):349-58. Review.

PMID:
10197293
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk